Effect of heme oxygenase-1 polymorphisms on lung function and gene expression

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Tanaka, Goh ^a   Aminuddin, Farzian ^a   Akhabir, Loubna ^a   He, Jian Qing ^a   Shumansky, Karey ^a   Connett, John E ^b   Anthonisen, Nicholas R ^c   Abboud, Raja T ^d   Paré, Peter D ^a   Sandford, Andrew J ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Heme oxygenase; Polymorphism

Indexed keywords

GENOMIC DNA; HEME OXYGENASE 1; HEMIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; HMOX1 PROTEIN, HUMAN; PRIMER DNA;

ADULT; ARTICLE; CELL STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; INTRON; LUNG ALVEOLUS MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; CLINICAL TRIAL; ENZYMOLOGY; GENE EXPRESSION; GENETICS; LUNG; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BASE SEQUENCE; DNA PRIMERS; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HEME OXYGENASE-1; HUMANS; LUNG; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 80052582951     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-117     Document Type: Article

References (24)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
2. Ryter SW, Choi AM. Therapeutic applications of carbon monoxide in lung disease. Curr Opin Pharmacol 2006, 6:257-262. 10.1016/j.coph.2006.03.002, 16580257.
3. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997, 94:10925-10930. 10.1073/pnas.94.20.10925, 23533, 9380736.
4. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 1999, 103:1047-1054. 10.1172/JCI5342, 408257, 10194478.
5. Silverman EK. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc 2006, 3:405-408. 10.1513/pats.200603-092AW, 2658703, 16799082.
6. He JQ, Ruan J, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002, 166:323-328. 10.1164/rccm.2111059, 12153964.
7. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O' Hara P, Owens GR, Scanlon PD, Tashkin DP, Wise RA. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994, 272:1497-1505. 10.1001/jama.272.19.1497, 7966841.
8. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981, 123:659-664.
9. Abecasis GR, Cookson WO. GOLD--graphical overview of linkage disequilibrium. Bioinformatics 2000, 16:182-183. 10.1093/bioinformatics/16.2.182, 10842743.
10. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004, 74:106-120. 10.1086/381000, 1181897, 14681826.
11. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942. 10.1093/bioinformatics/bti473, 15860560.
12. Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, Iwai N. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 2004, 173:315-319.
13. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000, 66:187-195. 10.1086/302729, 1288325, 10631150.
14. Wallace AM, Sandford AJ, English JC, Burkett KM, Li H, Finley RJ, Muller NL, Coxson HO, Pare PD, Abboud RT. Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema. COPD 2008, 5:13-23. 10.1080/15412550701817789, 18259971.
15. Ishii T, Wallace AM, Zhang X, Gosselink J, Abboud RT, English JC, Pare PD, Sandford AJ. Stability of housekeeping genes in alveolar macrophages from COPD patients. Eur Respir J 2006, 27:300-306. 10.1183/09031936.06.00090405, 16452584.
16. Burkett K, McNeney B, Graham J. A note on inference of trait associations with SNP haplotypes and other attributes in generalized linear models. Hum Hered 2004, 57:200-206. 10.1159/000081447, 15583426.
17. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45. 10.1093/nar/29.9.e45, 55695, 11328886.
18. Tanaka G, Sandford AJ, Burkett K, Connett JE, Anthonisen NR, Pare PD, He JQ. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 2007, 29:34-41.
19. Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, Laird N, Sylvia JS, Sparrow D, Speizer FE, Weiss ST, Silverman EK. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005, 33:71-78. 10.1165/rcmb.2005-0073OC, 2715305, 15817713.
20. Hersh CP, Demeo DL, Lazarus R, Celedon JC, Raby BA, Benditt JO, Criner G, Make B, Martinez FJ, Scanlon PD, Sciurba FC, Utz JP, Reilly JJ, Silverman EK. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:977-984. 10.1164/rccm.200509-1452OC, 2662917, 16456143.
21. Guenegou A, Leynaert B, Benessiano J, Pin I, Demoly P, Neukirch F, Boczkowski J, Aubier M. Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genet 2006, 43:e43. 10.1136/jmg.2005.039743, 2564599, 16882737.
22. Nakayama K, Kikuchi A, Yasuda H, Ebihara S, Sasaki T, Ebihara T, Yamaya M. Heme oxygenase-1 gene promoter polymorphism and decline in lung function in Japanese men. Thorax 2006, 61:921. 10.1136/thx.2006.066423, 2104761, 17008486.
23. Siedlinski M, van Diemen CC, Postma DS, Boezen HM. Heme oxygenase 1 variations and lung function decline in smokers: proof of replication. J Med Genet 2008, 45:400. 10.1136/jmg.2008.058123, 18519631.
24. Hirai H, Kubo H, Yamaya M, Nakayama K, Numasaki M, Kobayashi S, Suzuki S, Shibahara S, Sasaki H. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 2003, 102:1619-1621. 10.1182/blood-2002-12-3733, 12730098.